Dry Granulation Excipients Market Size & Share, by Product (Disintegrants & Lubricants, Organic Chemicals, Oleochemicals, Carbohydrates, Petrochemicals, and Others); Formulation (Oral formulation, Tablets, Capsules); End User (Pharmaceutical Companies, Chemical Industries, Research Institution) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5979
  • Published Date: Apr 03, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024 - 2036

Dry Granulation Excipients Market size is poised to reach USD 20 Billion by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of the dry granulation excipients was USD 12 Billion. The growth of dry granulation excipients growth is due to the burgeoning demand in the pharmaceutical and chemical industries. For instance, there are more than 20,000 pharmaceutical companies spread over more than 200 nations.  Better stability and shelf life are provided for pharmaceutical formulations by dry granulation. The granules generated by dry granulation have improved chemical stability due to reduced exposure to moisture, making the finished product last longer and be of higher quality. Hence, over time dry granulation excipients have gained popularity in the pharmaceutical industry.

In addition, a high demand for generic drugs due to generic drugs having nominal pricing than branded drugs boosting the number of drugs sold in the market. Which would support the pharmaceutical industry and accelerate dry granulation excipients market expansion during the projection period.


Dry Granulation Excipient Market
Get more information on this report: Request Free Sample PDF

Dry Granulation Excipients Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Healthcare Expenditure: Healthcare costs are rising at an exceptional rate due to factors like the high cost of treatment, increasing drug prices, and growth in medical enrollment which has increased the need for highly efficient and low-cost drugs in the market. Increased expenditure allows producers of excipients to fund research and development initiatives to create novel excipients suited to particular needs of the dry granulation procedure for creating affordable drugs in the market. According to research, in 2021 the global healthcare expenditure was 9.7% of the global GDP.
  • Technological Advancements in Drug Manufacturing: Technological advancements in dry granulation techniques, such as roller compaction involves compacting dry powders between two rollers to form a dense sheet, which is then milled into granules. This process offers advantages such as increased uniformity of granule size and improved flow properties, resulting in more consistent drug delivery.   and slugging which involves compressing powder blends into large tablets or "slugs," which are then broken down into granules. Slugging offers advantages such as simplicity and scalability, making it suitable for both small-scale and large-scale production. These innovations are enhancing the efficiency and effectiveness of drug formulation processes, leading to the expansion of dry granulation excipients.
  • Improved Access to Healthcare: Enhanced healthcare access drives a surge in demand for pharmaceuticals. As more individuals obtain vital medications, the need for pharmaceuticals rises. This increased demand extends to solid oral dosage forms, which rely on specific dry granulation excipients. Consequently, there is an expansion in the market for pharmaceutical manufacturers, resulting in a rise in the demand for excipients crucial in producing tablets and capsules.

Challenges

  • Delay in Approval: New excipient approval processes can be drawn out, costly, and complicated. Pharmaceutical businesses may find it more difficult to justify their investment in developing new medicines due to the high capital costs involved and the potential for further delays in the time to market for novel excipients. Furthermore, the FDA and other regulatory bodies must approve new excipients before they may be used in pharmaceutical products. Thus, negatively affecting the market expansion
  • Lengthy manufacturing process due to the production of excipients in large quantities to meet the needs of the pharmaceutical industry is expected to hinder market growth.
  • Several technical issues regarding the process of dry granulation can also impede the market growth in the forecast period.

Dry Granulation Excipients Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

~8%

Base Year Market Size (2023)

~ USD 12 Billion

Forecast Year Market Size (2036)

~ USD 20 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Dry Granulation Excipients Segmentation

Formulation (Oral formulation, Tablets, Capsules)

The oral formulations segment in the dry granulation excipients market is estimated to gain the largest revenue share of about ~42% in the year 2036. The segment growth can be attributed to its wide usage and efficacy against various diseases. For instance, 361.3 million medications are administered or prescribed annually, and 76.2% of consultations involve drug therapy. This high usage of oral formulations can be attributed to their convenience, ease of administration, and patent compliance. Dry granulation excipients play a vital role in formulating these dosage forms, as a result driving growth in the oral formulation segment.

Product (Disintegrants & Lubricants, Organic Chemicals, Oleochemicals, Carbohydrates, Petrochemicals, and Others)

The lubricants and glidants in the dry granulation excipients market are estimated to gain a significant share of about ~18% in the year 2036. The segment growth can be attributed to the high utilization in manufacturing of oral solid dosage forms which are the most popular form of dosage. Lubricants and glidants play a crucial role in dry granulation by improving the flow properties of powders and reducing friction between particles and equipment surfaces. This leads to smoother processing, reduced equipment wear, and increased manufacturing efficiency, driving the demand for lubricants and glidants in the dry granulation excipient market.

Our in-depth analysis of the dry granulation excipient market includes the following segments:

     Products

  • Disintegrants & Lubricants
  • Organic Chemicals
  • Oleochemicals
  • Carbohydrates
  • Petrochemicals
  • Others

    Formulation

  • Oral formulation
  • Tablets
  • Capsules

     End-User

  • Pharmaceutical Companies
  • Chemical Industries
  • Research Institution

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Dry Granulation Excipients - Industry Regional Synopsis

APAC Market Forecast

The dry granulation excipients market in the Asia Pacific region is anticipated to hold the largest share of about ~34% by the end of 2036. The market growth in the region is also expected on account of the rapidly expanding pharmaceutical industry in countries like China, Indonesia, India, Japan, and South Korea. Studies show that there are 3000 FDA-approved pharmaceutical companies in India additionally in South Korea, there were 653 pharmaceutical companies in 2022. This growth of the pharmaceutical industry can be attributed to the rising prevalence of chronic disease due to unhealthy lifestyles and high population rates in the region. Furthermore, countries in the Asia Pacific region like India which has one of the largest pharmaceutical industries in the world are hubs for generic drug manufacturing. This is due to the presence of major key players in the region, catering to both domestic and international markets. Dry granulation excipients are essential for formulating generic drugs, and the region's growing focus on generic pharmaceuticals contributes to the demand for these excipients.

European Market Analysis

The European dry granulation excipients market is estimated to be the second largest, registering a share of about ~24% by the end of 2036. The market’s expansion can be attributed majorly to the growing emphasis on superior generic pharmaceutical products due to economic pressure and healthcare cost containment efforts. For instance, currently, generic drugs account for around 50% of the European market by volume. Furthermore, the demand for oral solid dosage formulations in the region's growing aging population and the rising prevalence of chronic disease is also expected to propel the market growth. Moreover, the European region offers a conducive environment for the growth of the dry granulation excipient market, driven by stringent regulatory standards, increasing demand for oral solid dosage forms, advancements in pharmaceutical manufacturing, focus on patient compliance, high-quality drug delivery system, outsourcing trends, and innovation in drug delivery systems.

Research Nester
Dry Granulation Excipient Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Dry Granulation Excipients Landscape

top-features-companies
    • DFE Pharma
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Air Liquide group.
    • BASF
    • MultiMedia Pharma Sciences LLC
    • Colorcon
    • GEA Group
    • Wacker Chemie AG
    • Ashland Inc.
    • Roquette Freres

In-the-news

In The News

  • For particular industrial areas, the WACKER Group released its silicone-based product solutions. silicone gels for wound care, self-adhesive liquid silicone rubber grades that stick to polycarbonate and other high-performance plastics, and non-post-curing liquid silicone rubber for the food sector and medical technology are the main areas of attention. The focus is also on resource-efficient silicones and products for electromobility applications.
  • Ashland launched KlucelTM xtend, a controlled release matrix former made of hydroxypropyl cellulose (HPC), to provide the highest level of process versatility and release profile efficiency. It was the most recent product to be added to the company's KlucelTTM range, which broadens its portfolio of controlled releases.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5979
  • Published Date: Apr 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving the growth of the dry granulation excipients market are burgeoning demand in the pharmaceutical and chemical industries. technological advancements in dry granulation techniques, and rising healthcare expenditure.

The market size of the dry granulation excipients market is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.

The major players in the market are DFE Pharma, Gattefosse, BASF, MultiMedia Pharma Sciences, LLC, Colorcon, GEA Group, Aktiengesellschaft, Ashland Inc., Roquette Freres, and others.

The oral formulations segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Dry Granulation Excipient Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying